Literature DB >> 24551726

Immunohistochemical expression of p16 in Carcinoma Ex-pleomorphic Adenoma (undifferentiated and Adenocarcinoma Types).

Bassel Tarakji1, Mohammed Alsakran Altamimi2, Kusai Baroudi2, Mohammad Z Nassain2, Faris Q Alenzi3.   

Abstract

OBJECTIVE: This study was aimed at characterizing alterations in the immunohistochemical expression of p16 in carcinoma ex-pleomorphic adenomas. STUDY
DESIGN: A selected series of 27 cases of carcinoma ex-pleomorphic adenomas were examined.
RESULTS: The results showed that p16 expression in non tumour duct cells was strongly positive nuclear staining in 23 (85%) cases out of 27 cases, that 3 (11.1%) had moderate staining, and that 1 (3.7%) had weak staining. p16 expression in carcinoma ex-pleomorphic adenomas was indicated as a negative nuclear staining in 22 (81.4%) cases out of 27cases, and 5 (18.5%) cases expressed moderate staining.
CONCLUSION: This study suggests that alteration of p16 expression is detected in carcinoma ex-pleomorphic adenomas. p16 has a role in development of carcinoma ex-pleomorphic adenomas.

Entities:  

Keywords:  CDKN2 gene; p16 expression

Year:  2013        PMID: 24551726      PMCID: PMC3919315          DOI: 10.7860/JCDR/2013/7380.3851

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  19 in total

1.  Carcinoma ex pleomorphic adenoma of soft palate with cavernous sinus invasion.

Authors:  Hsuan-Ho Chen; Li-Yu Lee; Shy-Chyi Chin; I-How Chen; Chun-Ta Liao; Shiang-Fu Huang
Journal:  World J Surg Oncol       Date:  2010-03-30       Impact factor: 2.754

2.  Aberrant protein expression and promoter methylation of p16 gene are correlated with malignant transformation of salivary pleomorphic adenoma.

Authors:  Yu-Hua Hu; Chun-Ye Zhang; Zhen Tian; Li-Zhen Wang; Jiang Li
Journal:  Arch Pathol Lab Med       Date:  2011-07       Impact factor: 5.534

3.  The assessment of proliferating cell nuclear antigen (PCNA) immunostaining in human benign and malignant epithelial lesions of the parotid gland.

Authors:  Q Zhu; F H White; G L Tipoe
Journal:  Oral Oncol       Date:  1997-01       Impact factor: 5.337

Review 4.  Cell cycle regulators and their abnormalities in breast cancer.

Authors:  P L Fernández; P Jares; M J Rey; E Campo; A Cardesa
Journal:  Mol Pathol       Date:  1998-12

Review 5.  p16(INK4a)/CDKN2 expression and its relationship with oral squamous cell carcinoma is our current knowledge enough?

Authors:  Mario Pérez-Sayáns; José Manuel Suárez-Peñaranda; Pilar Gayoso-Diz; Francisco Barros-Angueira; José Manuel Gándara-Rey; Abel García-García
Journal:  Cancer Lett       Date:  2011-03-15       Impact factor: 8.679

6.  S100P expression in ductal type of carcinoma ex pleomorphic adenoma.

Authors:  Kazuki Hashimoto; Hidetaka Yamamoto; Hideki Shiratsuchi; Torahiko Nakashima; Sadafumi Tamiya; Yuichiro Higaki; Shizuo Komune; Masazumi Tsuneyoshi; Yoshinao Oda
Journal:  Am J Surg Pathol       Date:  2011-03       Impact factor: 6.394

7.  Frequent p16 inactivation by homozygous deletion or methylation is associated with a poor prognosis in Japanese patients with pleural mesothelioma.

Authors:  Naruyuki Kobayashi; Shinichi Toyooka; Hiroyuki Yanai; Junichi Soh; Nobukazu Fujimoto; Hiromasa Yamamoto; Shuji Ichihara; Kentaro Kimura; Kouichi Ichimura; Yoshifumi Sano; Takumi Kishimoto; Hiroshi Date
Journal:  Lung Cancer       Date:  2008-04-18       Impact factor: 5.705

8.  Histopathologic studies on carcinoma in pleomorphic adenoma of the parotid gland.

Authors:  K Nagao; O Matsuzaki; H Saiga; I Sugano; H Shigematsu; T Kaneko; T Katoh; T Kitamura
Journal:  Cancer       Date:  1981-07-01       Impact factor: 6.860

9.  Deletion of the p16 gene and microsatellite instability in carcinoma arising in pleomorphic adenoma of the parotid gland.

Authors:  H Suzuki; Y Fujioka
Journal:  Diagn Mol Pathol       Date:  1998-08

10.  Immunohistochemical Expression of p53 in Pleomorphic Adenoma and Carcinoma Ex Pleomorphic Adenoma.

Authors:  Bassel Tarakji; Omar Kujan; Mohammad Z Nassani
Journal:  J Cancer Epidemiol       Date:  2010-12-28
View more
  2 in total

1.  Carcinoma ex pleomorphic adenoma: case report and options for systemic therapy.

Authors:  N Chooback; Y Shen; M Jones; K Kasaian; M Martin; T Ng; T Thomson; M Marra; J Laskin; C Ho
Journal:  Curr Oncol       Date:  2017-06-27       Impact factor: 3.677

2.  Expression of p16Ink4a protein in pleomorphic adenoma and carcinoma ex pleomorphic adenoma proves diversity of tumour biology and predicts clinical course.

Authors:  Ewelina Bartkowiak; Krzysztof Piwowarczyk; Magdalena Bodnar; Paweł Kosikowski; Jadzia Chou; Aldona Woźniak; Małgorzata Wierzbicka
Journal:  J Clin Pathol       Date:  2021-05-03       Impact factor: 4.463

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.